Key Account Representative / Territory Manager
Avidity
Summary
We have a fantastic opportunity to join our team working with one of the top 4 global tobacco companies (British American Tobacco). Working in a fast-paced and dynamic environment your role is to support our client in delivering their key sales and marketing strategies.
Job description
Responsibilities
As a Key Account Representative you'll take responsibility for building and maintaining strong relationships with key decision makers within the forecourt, organised convenience & grocery channel. Day to day you will be helping drive sales through educating staff & key decision makers on our client's product portfolio and ensuring products are available and compliant.
What We're Looking For
- Experience working in field sales or similar role
- Strong communication skills and confidence influencing stakeholders
- Stakeholder management experience
- Excellent time management and territory planning ability
- Be self-motivated and results-driven
- A full UK Driving Licence (no more than 6 points and no previous bans)
Nice to Have
- Merchandising or POS execution experience
- Direct selling skills
Requirements
- Experience working in field sales or similar role
- Strong communication skills and confidence influencing stakeholders
- Stakeholder management experience
- Excellent time management and territory planning ability
- Self-motivated and results-driven
- Full UK Driving Licence (no more than 6 points and no previous bans)
- Merchandising or POS execution experience (nice to have)
- Direct selling skills (nice to have)
Benefits
- Performance Bonus
- Company Car
- Fuel Card
- Flexible Working Policies
- Paid Holiday
- Enhanced Sick Pay
- Maternity Leave
- Paternity Leave
- Carers Leave
- Parental Leave
- Employee Assistance Programme
- Private Healthcare
- Life Assurance
- Lunch Allowance
Company overview
Avidity Biosciences is a pioneering biotechnology company focused on developing a new class of RNA-targeted therapeutics called Antibody Oligonucleotide Conjugates (AOCs). The company's proprietary AOC platform combines the tissue selectivity of monoclonal antibodies with the precision of oligonucleotide therapies to address previously undruggable targets. Avidity is advancing a pipeline of innovative treatments for serious diseases, with a primary focus on rare muscle disorders and cardiac conditions. The company's lead program targets myotonic dystrophy type 1 (DM1), a progressive genetic disorder affecting multiple organ systems. Avidity's technology platform enables targeted delivery of oligonucleotides to specific tissues and cell types, overcoming traditional delivery challenges in RNA therapeutics. The company has established strategic partnerships and collaborations to advance its research and development programs, positioning itself at the forefront of next-generation RNA-targeted medicine.